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Abstract 
Background: Streptococcus suis is a major cause of meningitis, arthritis, and pneumonia in pigs worldwide, and 
an emerging pathogen in humans. In Sweden, S. suis has previously received little attention but has in recent years 
become increasingly recognized as affecting the pig production. The aim of the present study was to investigate the 
occurrence, serotypes and antimicrobial susceptibility of S. suis in Swedish grower pigs from herds with and without 
reported S. suis associated disease, as well as possible associations between S. suis associated disease and selected 
environmental and production factors. Swab samples were taken from the tonsils of clinically healthy 8–13-week-old 
grower pigs from ten case herds and ten control herds. Isolates were cultured, identified using MALDI–TOF MS, and 
serotyped using latex agglutination. The antimicrobial susceptibility of 188 isolates was tested using broth microdilu-
tion. Production data was gathered and environmental parameters were measured on the farms.
Results: Streptococcus suis was isolated from 95% of the sampled pigs in both the case and the control herds. Sero-
types 3, 4, 5, 7, 9, 10, 11, 15, 16, and 17–34 were detected, although a majority of the isolates (81.5%) were non-type-
able. There was less diversity among the serotypes isolated from the case herds than among those from the control 
herds; four and nine different serotypes, respectively. Isolates resistant to penicillin (3.8%) were reported for the first 
time in Sweden. Tetracycline resistance was common (88.4%). No association was noted between the production and 
the environmental factors investigated, and the carriership of S. suis.
Conclusions: The carriership of S. suis was found to be higher in clinically healthy Swedish pigs than previously esti-
mated, and for the first time, the presence of Swedish isolates resistant to penicillin was reported. Many of the most 
commonly disease-associated serotypes, e.g. serotypes 2, 9, 3, and 7, were detected in healthy grower pigs although 
further studies are needed to investigate the virulence of these isolates.
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Background
Streptococcus suis is considered one of the most impor-
tant pathogens affecting pig production worldwide and 
is also an emerging zoonotic agent in humans. In both 
humans and pigs, S.  suis may cause meningitis, sepsis, 
arthritis, pneumonia, endocarditis, and acute death [1, 
2]. Pigs carry the bacteria in the tonsils and on the nasal 
mucosa, as well as in the gastrointestinal and genital 
tracts [3, 4], and healthy carrier animals are thought to 
be present on most pig farms. Transmission of bacteria 
between pigs occurs mainly via the respiratory route [5], 
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Environmental factors such as higher outside tempera-
ture, excessive temperature fluctuations, and high air 
relative humidity have been associated with a higher pro-
portion of S. suis carriership, as have production factors 
such as crowding and continuous production systems [7, 
8]. Further, infection with porcine reproductive and res-
piratory syndrome (PRRS) virus may predispose pigs to 
secondary S. suis-infections [9].
Presumptive diagnosis in pigs is based on clinical signs 
and should be confirmed by necropsy and isolation of 
the pathogen. S. suis is a phenotypically and genetically 
diverse species with a complex taxonomy and may be 
challenging to accurately identify in the laboratory. Based 
on the antigenicity of the polysaccharide capsule, 35 
serotypes were initially described, although sequencing 
of the 16S rRNA and cpn60 genes has more recently indi-
cated that six of these belong to other species [10–12]. 
The serotypes most commonly isolated from diseased 
pigs are 2, 9, 3, 1/2, and 7 [13], and individual pigs fre-
quently carry more than one serotype [14, 15]. Relatively 
high levels of resistance to some antimicrobials (e.g. mac-
rolides, lincosamides, tetracyclines, and sulphonamides) 
have been reported in many countries, while resistance to 
penicillins has generally been described as low [16].
Although the first Swedish reports of S. suis-infections 
in pigs and humans were published in the mid-1980s [17, 
18], this pathogen has until recently received little atten-
tion. However, two more human cases were reported in 
2014 [19, 20], and veterinarians in clinical practice have 
noticed an increase in pigs showing clinical signs indica-
tive of S.  suis-infection. Therefore, the aim of this study 
was to investigate the occurrence, serotypes and antimi-
crobial susceptibility of S.  suis in Swedish grower pigs 
from farms with and without reported disease, as well 
as possible associations with selected environmental and 
production factors.
Methods
The study was approved by the Ethics Committee 
for Animal Experimentation, Uppsala, Sweden (Dnr 
5.8.18-15404).
Study design
A case–control design was used. Herds were chosen 
based on the referrals of herd health veterinarians from 
the Swedish “Farm & Animal Health” service that covers 
80% of the Swedish pig herds. The case group included 
ten pig herds where the health-service veterinarian had 
previously diagnosed S. suis-infections and clinical signs 
had been noted in several batches of weaned pigs dur-
ing the year preceding the sampling. An equal number 
of herds where no such diagnoses had ever been made 
by the herd health veterinarians were used as controls. 
No selected herds opted out of participating. For the 
purposes of this study, clinical signs indicative of S. suis-
infection were defined as grower pigs (from weaning to 
30 kg body weight) circling or exhibiting seizures, lateral 
recumbency with paddling leg movements, or severe 
pneumonia in herds where S. suis pneumonia had previ-
ously been laboratory confirmed.
Herds
The samples were collected during 2018 and 2019 from 
20 farms located in the south and central parts of Swe-
den, in the counties with the highest pig density. The 
herds included piglet producing, farrow-to-finish, and 
gilt producing conventional herds, as well as piglet pro-
ducing and farrow-to-finish organic herds, and piglet 
producing and farrow-to-finish sow pool satellites (i.e., 
a multi-site production system with a central unit for 
mating and pregnant sows, and several satellite herds 
where farrowing and piglet production takes place [21]). 
In accordance with the Swedish legislation [22], growth-
promoting antibiotics or growth-promoting hormones 
were not used. Further, the Swedish pig production is 
declared free from PRRS virus, and an active surveillance 
programme is in place [23].
Data collection
In each farm, environmental measurements were col-
lected from the room housing the targeted pigs. Tem-
perature and air relative humidity were measured at the 
height of approximately 1  m in the middle of the room 
using a Testo 625 thermohygrometer (Testo SE & Co. 
KGaA, Lenzkirch, Germany). The air velocity was meas-
ured at the height of approximately 0.1  m in 2–6 ran-
domly distributed pens per room, adjacent to the solid 
and to the slatted floor areas (or, where applicable, adja-
cent to the deep straw bedding), using a Testo  405-V1 
thermal anemometer (Testo SE & Co. KGaA). Carbon 
dioxide was measured at the height of approximately 
1 m in the middle of the room and ammonia was meas-
ured at the height of approximately 0.1 m adjacent to the 
slatted floor area in 4–6 randomly distributed pens per 
room, (or, where applicable, adjacent to the deep straw 
bedding), using colorimetric detector tubes and a man-
ual GV-100 air sampling pump (GASTEC Corporation, 
Kanagawa, Japan).
Information on management practices and production 
data covering 1 year before sampling was obtained from 
the farmers through interviews and from the farm man-
agement software PigVision (AgroVision B.V., Deventer, 
Netherlands). All data collection was performed by the 
first author. Mean values for the case and control group 
were compared using a two-tailed t-test, and P < 0.05 was 
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considered significant. Statistical analysis was performed 
in R version 3.6.2 [24].
Bacterial sampling
From each farm, samples were taken from ten clinically 
healthy grower pigs from the same batch, if possible from 
one pig per pen. The pigs were 8–13 weeks of age and had 
not been subjected to any treatment for at least 1 month 
before sampling. The pigs had all been weaned at between 
4 and 6 weeks of age [25]. A sample was obtained from 
each pig’s palatine tonsils by opening the mouth using 
snares of braided nylon rope around the upper and lower 
jaws and rubbing an eSwab™ 480CE (Copan Diagnostics, 
Inc., Corona, CA, USA) on the tonsillar surface for 3  s. 
The swabs were immediately placed in tubes containing 
liquid Amies transport medium, transported to the labo-
ratory at ambient temperature, and were processed for 
bacteriological analysis within 18 h of sampling.
Bacterial isolation and identification
The swabs were streaked directly onto streptococ-
cal selective colistin-oxolinic acid-blood agar (COBA) 
plates (National Veterinary Institute, Uppsala, Swe-
den), and incubated at 37 °C in 5%  CO2 overnight. From 
each sample, 5–12 small, translucent colonies exhibit-
ing α- or β-hemolysis [26] were subcultivated on 5% 
horse blood agar plates (National Veterinary Institute) 
and incubated at 37  °C in 5%  CO2 overnight. Following 
incubation, matrix-assisted laser desorption ionization-
time of flight mass spectrometry (MALDI-TOF MS) 
was used to identify the bacterial colonies to the spe-
cies level. Material from 1 to 3 pure-cultured colonies 
was smeared directly onto a polished steel target (Bruker 
Daltonik GmbH, Bremen, Germany), covered with 1 μL 
of α-cyano-4-hydroxycinnamic acid (HCCA) matrix 
(Bruker Daltonik GmbH), prepared according to the 
manufacturer’s instructions, and allowed to dry at room 
temperature. MALDI-TOF MS analysis was performed 
using a Microflex LT System running version 4.1.60 of 
the BDAL database (Bruker Daltonik GmbH). A positive 
species identification was defined as a MALDI-TOF MS 
score ≥ 2.00 [27]. Isolates identified with low confidence 
(MALDI-TOF MS scores between 1.70 and 1.99) were re-
tested using the direct transfer-formic acid method [28], 
where 1 μL of 70% formic acid (Sigma-Aldrich, Stein-
heim, Germany) was added to the bacteria on the target 
spot and allowed to air dry before matrix solution was 
added and analysis performed. A maximum of five con-
firmed S. suis isolates per pig were preserved at − 70 °C, 
and later one isolate per pig was randomly selected for 
serotyping and antimicrobial susceptibility testing.
Serotyping by latex agglutination
Isolates were serotyped by latex agglutination [20, 29] 
using the commercially available Immulex™ S. suis kit 
(SSI Diagnostica A/S, Hillerød, Denmark) according 
to the manufacturer’s instructions. The test identifies 
serotypes 1 through 16 separately, and groups serotypes 
17 through 34 together. Briefly, 1 μL of colony material, 
pure-cultured on 5% horse blood agar at 37  °C in 5% 
 CO2 overnight, was suspended in 250 μL of sterile saline 
before mixing 10 μL of the suspension with 10 μL of latex 
reagent. Agglutination that occurred within 60  s was 
interpreted as a positive reaction.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed by 
broth microdilution using commercially available Vet-
MIC GP-mo panels (National Veterinary Institute), 
according to the manufacturer’s instructions. Isolates 
were cultured on 5% horse blood agar plates and incu-
bated at 37  °C in 5%  CO2 overnight. Colonies were sus-
pended in a 0.9% sterile saline solution to obtain an 
inoculum density of 5 × 105 colony-forming units per mL 
(CFU/mL), which was added to cation-adjusted Muel-
ler–Hinton broth (National Veterinary Institute) supple-
mented with 3% lysed horse blood (Håtunalab AB, Bro, 
Sweden). Each of the 96 wells of a VetMIC GP-mo plate 
was inoculated and incubated aerobically at 37  °C for 
18–20 h. S. suis ATCC 43765 and Streptococcus pneumo-
niae ATCC 49619 were used as control strains and mini-
mum inhibitory concentrations (MIC) were within the 
accepted quality control ranges. The MIC was recorded 
as the lowest concentration of an antimicrobial inhibit-
ing visible bacterial growth. MICs of cefoxitin, cefalotin, 
ciprofloxacin, clindamycin, chloramphenicol, enrofloxa-
cin, erythromycin, gentamycin, penicillin, tetracycline, 
trimethoprim, and trimethoprim/sulfamethoxazole 
were determined. The results were interpreted accord-
ing to Clinical and Laboratory Standards Institute (CLSI) 
breakpoints for S. suis [30], where available.
Results
Herds
The case group consisted of seven farrow-to-finish herds 
and three piglet-producing herds. Out of the ten case 
herds, three were sow pool satellites from different sow 
pools. The control group consisted of eight farrow-to-
finish herds, one gilt-producing, and one piglet-produc-
ing herd. Out of the ten control herds, two were specific 
pathogen-free (SPF) herds [31] and three were organic 
herds providing access to outside pastures or exercise 
yards for the pigs. All in-all out production was practiced 
consistently in all but one case and one control herd. The 
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time for which the nursery pig barns were allowed to sit 
empty between batches varied between and within herds, 
in the case group from 0 to 21  days and in the control 
group from 0 to 7 days.
Clinical signs indicative of meningitis predominated in 
eight out of ten case herds, while two herds reported res-
piratory signs and acute deaths due to S. suis. All herds 
had recorded at least one case during the month preced-
ing the sampling. At the interviews, three control herds 
reported that single pigs with clinical signs consistent 
with an S. suis-infection had been observed by the farm-
ers on single occasions. These potential cases had how-
ever not been clinically confirmed by the herd health 
veterinarians.
There were no significant differences between case and 
control herds in the environmental parameters measured 
(Table 1). Taking the farm owners’ reports into account 
and reclassifying the three control herds reporting occa-
sional cases as case herds, did not affect these results.
No significant differences were found between the case 
and control herds regarding the production data param-
eters (Table  2). However, reclassifying the three control 
herds reporting occasional cases as case herds resulted 
in the number of sows farrowing per batch being signifi-
cantly lower (P = 0.01) in the control herds (n = 7; mean 
22.7, SD 12.5) than in the case herds (n = 13; mean 40.1, 
SD 13.0).
The total number of sows in the sow pools ranged from 
1000 to 1700, with between 40 and 55 sows farrowing in 
each batch at the sampled satellite farms.
Bacterial sampling
Streptococcus suis was isolated from at least eight out of 
ten (mean 9.5, SD 0.7) of the sampled animals in each 
control herd, and from at least eight out of ten (mean 9.5, 
SD 0.7) of the sampled animals in each case herd. In total, 
S. suis was isolated from 95% (190 out of 200) of the sam-
pled animals included in the study.
Serotyping
Latex agglutination was performed on 189 out of 190 
isolates (one isolate could not be re-cultivated for anal-
ysis). A majority of the isolates (81.5%, 154 out of 189) 
Table 1 Environmental parameters investigated in  20 
Swedish pig herds with  (case herds) and  without  (control 
herds) a history of  Streptococcus suis-infections in grower 
pigs
a Biosecurity rules in one herd prohibited measuring equipment being brought 
in
b P values were calculated using Welch’s t-test. P < 0.05 was considered 
significant
c Herds using deep straw bedding not included, leaving control herds n = 6 and 
case herds n = 9






Mean SD Mean SD
Temperature (°C) 20.4 3.42 19.5 3.95 0.59
Carbon dioxide (ppm) 1622 950 1550 695 0.85
Ammonia in pens, mean (ppm) 6.6 3.3 6.6 2.6 0.63
Air relative humidity (%) 55.9 17.5 58.4 12.4 0.73
Air velocity (solid floor or deep 
straw bedding), mean (m/s)
0.10 0.05 0.09 0.03 0.34
Air velocity (slatted floor), mean 
(m/s)c
0.14 0.08 0.07 0.03 0.10
Table 2 Production data from  20 Swedish pig herds with  (case herds) and  without  (control herds) a  history 
of Streptococcus suis-infections in grower pigs
All data parameters were not available for all herds (n = number of herds included)
a Mean values for Sweden according to the InterPIG report 2018 [49]
b Sow pools not included
c Nurse sows were used in one of the control herds and six of the case herds
Production parameters Sweden  2017a Control herds Case herds P value
Mean n Mean SD n Mean SD
Sows in  productionb 354 9 223.1 178.8 7 424.3 345.9 0.15
Sows farrowing per batch n/a 10 28.7 14.2 10 39.3 14.8 0.12
Litters/sow/yearb 2.24 6 2.12 0.27 6 2.20 0.06 0.49
Piglets born alive/litter 14.3 7 14.0 0.9 8 14.5 0.7 0.34
Pigs weaned/litterc 11.9 7 11.3 1.1 8 11.9 0.7 0.22
Pigs weaned/sow/yearb 26.6 6 24.0 4.6 6 26.6 1.4 0.24
Age at weaning (days) 32.8 10 36.0 4.2 10 33.2 3.3 0.11
Gilt recruitment (%) 24.8 9 25.7 9.5 8 29.0 5.5 0.40
Farrowing interval (weeks) n/a 10 3.4 1.7 10 2.5 1.1 0.18
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exhibited insufficient or no agglutination and were 
therefore serologically non-typeable. The percentage of 
non-typeable isolates did not differ (82.1% and 80.9%, 
respectively) between case and control herds. The distri-
bution of serotypes is shown in Fig. 1.
Serotype 5 was detected only in one case herd, whereas 
serotypes 3, 4, 7, 9, 10, and 16 were detected only in the 
control herds. The isolates of serotypes 3, 4, 7, 10, and 16 
were from one herd each, whereas serotype 9 was found 
in two herds. Serotypes 11, 15, and 17–34 were detected 
in both case and control herds.
Reclassification of the three previously mentioned con-
trol herds with occasional single cases of suspected S. 
suis-infections as case herds, resulted in one isolate from 
each of the serotypes 3, 7, 9, 15, and 16 being included in 
the case group.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing (Table  3) was per-
formed on 188 of the 190 isolates obtained from clini-
cally healthy pigs (two isolates could not be re-cultivated 
for analysis). Susceptibility to penicillin was determined 
for 184 isolates (four isolates were not able to grow in 
the presence of the citric acid-containing buffer used for 
penicillin).
Several isolates (9.2%, 17 out of 184) were classified 
as intermediate, and 3.8% (7 out of 184) were resistant 
to penicillin. A majority of these not susceptible iso-
lates (87.5%, 21 out of 24), including all of the resistant 
isolates, originated from the case herds. The percent-
age of isolates not susceptible to enrofloxacin was 27.7% 
in the case group and 21.3% in the control group while 
the percentages of isolates not susceptible to tetracy-
cline were similar in the two groups, at 100% and 98.9%, 
respectively.
Discussion
Compared to the limited historical data available [32, 
33], S. suis was isolated from a higher percentage than 
expected of clinically healthy Swedish grower pigs in 
both case and control herds. There was no difference in 
the percentage of carriers between the groups, and inter-
estingly, the conventional herds did not differ in this 
respect from the closed SPF-herds or the organic herds 
with lower stocking density and outdoor access.
In contrast to previous studies on Swedish isolates [33, 
34] the present study reports the occurrence of reduced 
susceptibility and resistance to penicillin. This is notable 
since penicillin resistance in S. suis is generally reported 
to be uncommon [16], and since Sweden has very low 
sales of antimicrobials for the use in food-producing ani-
mals [35]. In Sweden, benzylpenicillin is the most com-
mon antibiotic sold for the use in pig production, and in 
2014 the consumption of antibiotics for pigs consisted of 
75% products for injection, of which 60% were products 
containing benzylpenicillin [36]. A majority of the not 
susceptible isolates originated from case herds, which 
may be because of potentially higher use of antibiotic 
substances in these herds.
Despite the low Swedish sales of tetracyclines, as com-
pared to sales in other European countries [35, 37], the 
present study demonstrates a very high percentage of 
isolates, 100% of isolates from the case group and 98.9% 
isolates from the control group, to be “not susceptible” 
i.e. intermediate or resistant, to tetracycline. Out of all 
the tested isolates, 88.4% were resistant to tetracycline, 
which is markedly higher than the 7.7% reported in 1998 
[33], and the 82.0% reported in 2017 [34].
Using the CLSI breakpoints defined for enrofloxacin 
[30], 73.4% of the isolates were classified as susceptible. 
It is of note that the breakpoint has been determined for 
a dose of 7.5 mg/kg [38], and it is not valid for lower dos-
ages such as the one authorized in Sweden (5  mg/kg). 
Serotype 5; 1 isolate
Serotype 11; 2 isolates
Serotype 15; 2 isolates
Serotypes 17-34; 
12 isolatesNon-typeable; 
78 isolates       
b
Serotype 3; 1 isolate
Serotype 4; 1 isolate
Serotype 7; 1 isolate
Serotype 9; 2 isolates
Serotype 10; 3 isolates
Serotype 11; 1 isolate
Serotype 15; 2 isolates






Fig. 1 Serotypes of Streptococcus suis isolated from the tonsils of 
clinically healthy 8–13-week-old grower pigs (n = 189) in Sweden. 
One isolate per pig was tested with latex agglutination. a Isolates 
(n = 94) from ten control herds with no history of S. suis-infections. b 
Isolates (n = 95) from ten case herds with a history of S. suis-infections
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Table 3 Antimicrobial susceptibility of  188 Streptococcus suis isolates from  clinically healthy Swedish grower 
pigs from  ten control herds without  a  history of  Streptococcus suis-infections and  ten case herds with  a  history 






Distribuon (%) of MICs (mg/L)
≤0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 ≥64
3a) Distribuon of MICs and occurrence of resistance in S. suis (n = 94) from control herds
Cefalon 1.1 23.4 27.7 29.8 11.7 6.4
Cefoxin 1.1 5.3 9.6 18.1 21.3 (44.7)
Chloramphenicol 0 0 4.3 35.1 60.6 0 0 0
Ciprofloxacin 0 17.0 62.8 16.0 3.2 1.1
Clindamycin 26.6 4.3 2.1 1.1 8.5 20.2 5.3 31.9
Enrofloxacin 2.1 0 16.0 62.8 19.1 2.1 0
Erythromycin 66.0 0 0 3.2 5.3 1.1 2.1 (22.3)
Gentamycin 0 1.1 7.4 30.9 38.3 22.3 0 0
Penicillina 0 34.4 37.6 19.4 5.4 3.2 0 0 0
Tetracycline 85.1 1.1 13.8 28.7 20.2 7.4 1.1 23.4 4.3
Trimethoprim 68.1 4.3 3.2 0 7.4 7.4 9.6
Trim/Sulfb 78.7 3.2 3.2 4.3 7.4 1.1 2.1
3b) Distribuon of MICs and occurrence of resistance in S. suis (n = 94) from case herds
Cefalon 4.3 11.7 11.7 29.8 26.6 13.8 (2.1)
Cefoxin 8.5 0 6.4 5.3 16.0 (63.8)
Chloramphenicol 0 2.1 3.2 28.7 61.7 4.3 0 0
Ciprofloxacin 1.1 14.9 56.4 19.1 6.4 2.1
Clindamycin 26.6 5.3 2.1 4.3 1.1 20.2 9.6 30.9
Enrofloxacin 8.5 1.1 14.9 56.4 19.1 6.4 2.1
Erythromycin 59.6 4.3 2.1 1.1 4.3 2.1 3.2 (23.4)
Gentamycin 1.1 0 6.4 34.0 35.1 21.3 2.1 0
Penicillinc 7.7 18.7 17.6 16.5 24.2 15.4 5.5 2.2 0
Tetracycline 91.5 0 8.5 17.0 22.3 6.4 1.1 35.1 9.6
Trimethoprim 53.2 1.1 6.4 11.7 4.3 4.3 19.1
Trim/Sulfb 60.6 8.5 8.5 7.4 10.6 2.1 2.1
Isolates from (3a) case herds and (3b) control herds were obtained during 2018–2019 and tested using broth microdilution. Species-specific breakpoints according 
to CLSI 2018 [30] are indicated with single vertical lines (sensitive) and double vertical lines (resistant). Values for the lowest concentration tested indicate MICs lower 
than or equal to the lowest concentration within the range. Parentheses indicate isolates with MICs above the dilution range included in the test panel
a n = 93 in the case of penicillin
b Concentration for trimethoprim given, tested in combination with sulfamethoxazole in a concentration ratio of 1:20
c n = 91 in the case of penicillin
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Thus, the clinical usefulness of enrofloxacin for the treat-
ment of S. suis infections is questionable.
All of the isolates investigated originated from clini-
cally healthy pigs, and several previous studies have also 
shown that resistance to several classes of antibiotics is 
more common in non-clinical isolates than in isolates 
from diseased pigs [39–42]. It must also be considered 
that differences in the sampling strategies, susceptibility 
testing methodologies, and interpretive criteria applied, 
complicate comparisons of antimicrobial susceptibility 
data from different studies. Additionally, the lack of spe-
cies-specific veterinary clinical breakpoints for several 
classes of antibiotics hampers the clinical interpretation 
of the results.
Environmental factors such as higher outside tempera-
ture, temperature fluctuations, and a relative humidity 
of > 70%, have previously been associated with a higher 
carriership of S. suis in clinically healthy pigs [7, 8]. In 
the present study, the relative humidity and temperature 
in the room were measured once before bacterial sam-
pling commenced, and no association was found between 
these parameters and the carriership of S. suis. Tempera-
ture logging, outside and in the pig barn, over a longer 
period of time and in a greater number of herds may be 
considered in the future when assessing possible disease-
triggering factors.
In addition, none of the investigated production fac-
tors differed significantly between case and control herds. 
However, if the three herds that had experienced sin-
gle clinical cases of presumptive S. suis-infections were 
reclassified as case herds, the number of sows farrowing 
per batch was significantly higher in this group. Since 
the number of routes of transmission increases with an 
increasing number of individuals this might indicate that 
the group size is of importance. However, production 
data was not available for some herds, and care should be 
taken when interpreting these results.
The herds in the study were included in the case or 
control group solely based on their herd health veterinar-
ian’s assessment, as judged by the clinical picture and lab-
oratory results. The few participating SPF- and organic 
farms were all found in the control group, which could 
indicate that clinical problems with S. suis are less com-
mon problem in these herds. However this interesting 
observation needs further investigations.
Several of the most commonly disease-associated S. 
suis serotypes, e.g. serotypes 9, 3, and 7, were detected in 
clinically healthy pigs this study. S. suis is often consid-
ered part of the normal flora of the tonsils, and although 
certain serotypes are more often associated with dis-
ease, virulence can also vary within serotypes [43]. The 
diversity among the serotypes was lower in the case 
herds than in the control herds; four and nine serotypes, 
respectively. It is, however, difficult to draw any conclu-
sions based on the present results. A majority (81.5%, 154 
out of 189) of the investigated isolates were non-typeable 
using the latex agglutination method. This result may 
be due to poor sensitivity of the method used but is in 
accordance with several previous studies that, depend-
ing on the method used, have demonstrated up to 67% 
of isolates from clinically healthy pigs to be non-typeable 
[40, 43–45]. These isolates may be non-encapsulated or 
possess novel capsular polysaccharide loci [46]. The sero-
type group 17–34 encompasses six serotypes (20, 22, 26, 
32, 33, and 34) that have been reclassified as S. parasuis, 
S.  orisratti, and S.  ruminantium [11, 12, 47]. Thus, fur-
ther studies are needed to assess the virulence of these 
isolates. Other serotyping methods, e.g. in silico serotyp-
ing based on whole-genome sequencing, may be useful to 
further investigate the serotypes present in Sweden.
The perceived low incidence of clinical disease in 
Sweden may be due to low virulence of the strains pre-
sent, or it may be related to other factors such as a high 
weaning age, a legislated minimum space allowance 
for growing pigs that is higher than the EU minimum 
[25, 48], or to the generally high health standard of pig 
herds, e.g. the freedom from PRRS virus [23]. There is 
however also the possibility that S.  suis-infection may 
be underreported or misdiagnosed, and that the path-
ogen might be a more common cause of disease than 
previously acknowledged. Further, the possibility of 
the MALDI–TOF MS method generating false-positive 
results cannot be excluded.
Conclusion
This study shows S. suis to be more common in Swed-
ish pig herds than previously estimated, and for the 
first time reports the presence of Swedish isolates 
resistant to penicillin. Several of the most commonly 
disease-associated serotypes were isolated from clini-
cally healthy grower pigs, although a large number of 
isolates were serologically non-typeable using latex 
agglutination. Further studies are needed to investigate 
the serotypes and virulence of these isolates. No asso-
ciation was noted between the environmental factors 
investigated and the carriership of S. suis in clinically 
healthy grower pigs.
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